Statin intolerance and diabetes risk: What do we know?

Name: Statin intolerance and diabetes risk: What do we know?
Uploaded: 2014-11-24T00:00:00+00:00
Description: Mayo Clinic director of Exercise Testing and Sports Cardiology, Thomas G. Allison, Ph.D., Francisco Lopez-Jimenez, M.D., director of Preventive Cardiology, and Vinaya Simha, M.D., M.B.B.S., endocrinologist and specialist in lipidology, discuss statin intolerance.

Mayo Clinic director of Exercise Testing and Sports Cardiology, Thomas G. Allison, Ph.D., Francisco Lopez-Jimenez, M.D., director of Preventive Cardiology, and Vinaya Simha, M.D., M.B.B.S., endocrinologist and specialist in lipidology, discuss statin intolerance.

Published

November 24, 2014

Created by

Related Videos

Mayo Clinic Healthy Living Program for optimization of bone health

Kurt A. Kennel, M.D., from the Division of Endocrinology, Diabetes, Metabolism, and Nutrition, and Alynn C. Dukart, P.T., D.P.T., from the Healthy Living Program, discuss the importance of exercise to optimize bone health and what the ...

Insulin pumps and sensors: Treating diabetes with technology at Mayo Clinic

Yogish C. Kudva, M.B.B.S., an endocrinologist at Mayo Clinic's campus in Rochester, Minnesota, describes the Diabetes Technology Clinic, which focuses on the care of people who are currently using or are interested in using technology to manage their diabetes.

Advances in interventional cardiology: Treating diabetics and chronic stable angina

What are the most important recent interventional studies? David R. Holmes Jr., M.D., John F. Bresnahan, M.D., Bernard J. Gersh, M.B., Ch.B., D.Phil., and Rajiv Gulati, M.D., Ph.D., gathered to discuss FREEDOM and FAME II and review how ...

Medical Professional Video Center

Search Video Center